{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:08:04Z","timestamp":1789178884907,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.jp","jtcvsopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTCVS Open"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xjon.2026.101623","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:42:13Z","timestamp":1770856933000},"page":"101623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Feasibility and oncologic outcomes of minimally invasive surgery after induction chemoimmunotherapy for non\u2013small cell lung cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"Giovanni M.","family":"Comacchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay See","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Toumbacaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Bott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad S.","family":"Adusumilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Chidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Isbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie W.","family":"Rusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Sihag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1655-4473","authenticated-orcid":false,"given":"Daniela","family":"Molena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.xjon.2026.101623_bib3","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.xjon.2026.101623_bib4","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non\u2013small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.xjon.2026.101623_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa2215530","article-title":"Perioperative nivolumab and chemotherapy in stage III non\u2013small-cell lung cancer","volume":"389","author":"Provencio","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.xjon.2026.101623_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non\u2013small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.xjon.2026.101623_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jtcvs.2022.12.006","article-title":"Safety and feasibility of minimally invasive lobectomy after neoadjuvant immunotherapy for non\u2013small cell lung cancer","volume":"166","author":"Mathey-Andrews","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.xjon.2026.101623_bib8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jtcvs.2022.01.019","article-title":"Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non\u2013small cell lung cancer","volume":"164","author":"Sepesi","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.xjon.2026.101623_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtcvs.2018.11.124","article-title":"Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non\u2013small cell lung cancer","volume":"158","author":"Bott","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.xjon.2026.101623_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.athoracsur.2018.02.030","article-title":"Safety and feasibility of lung resection after immunotherapy for metastatic or unresectable tumors","volume":"106","author":"Bott","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.xjon.2026.101623_bib11","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jtcvs.2023.09.073","article-title":"Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non\u2013small cell lung cancer","volume":"167","author":"Feldman","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.xjon.2026.101623_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1158\/1078-0432.CCR-22-2994","article-title":"Five-year clinical outcomes after neoadjuvant nivolumab in resectable non\u2013small cell lung cancer","volume":"29","author":"Rosner","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.xjon.2026.101623_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.xjon.2026.101623_bib14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-5223(19)40289-4","article-title":"Multiple primary lung cancers","volume":"70","author":"Martini","year":"1975","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.xjon.2026.101623_bib15","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jtcvs.2017.09.151","article-title":"Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma","volume":"155","author":"Brandt","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.xjon.2026.101623_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jtcvs.2024.08.012","article-title":"Determinants of successful minimally invasive surgery for resectable non-small cell lung cancer after neoadjuvant therapy","volume":"169","author":"Chu","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.xjon.2026.101623_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/ejcts\/ezu028","article-title":"Revised ESTS guidelines for preoperative mediastinal lymph node staging for non\u2013small cell lung cancer","volume":"45","author":"De Leyn","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"10.1016\/j.xjon.2026.101623_bib18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1200\/JCO.21.01589","article-title":"Preoperative and postoperative systemic therapy for operable non\u2013small-cell lung cancer","volume":"40","author":"Chaft","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.xjon.2026.101623_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103582","article-title":"PD-L1 expression and tumor mutation burden as pathological response biomarkers of neoadjuvant immunotherapy for early-stage non\u2013small cell lung cancer: a systematic review and meta-analysis","volume":"170","author":"Deng","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"10.1016\/j.xjon.2026.101623_bib20","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.3390\/cancers13112603","article-title":"Surgery after induction targeted therapy and immunotherapy for lung cancer","volume":"13","author":"Allaeys","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.xjon.2026.101623_bib21","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","volume":"18","author":"Seymour","year":"2017","journal-title":"Lancet Oncol"}],"container-title":["JTCVS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266627362600046X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266627362600046X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:30:59Z","timestamp":1789176659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266627362600046X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":19,"alternative-id":["S266627362600046X"],"URL":"https:\/\/doi.org\/10.1016\/j.xjon.2026.101623","relation":{},"ISSN":["2666-2736"],"issn-type":[{"value":"2666-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility and oncologic outcomes of minimally invasive surgery after induction chemoimmunotherapy for non\u2013small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"JTCVS Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjon.2026.101623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.","name":"copyright","label":"Copyright"}],"article-number":"101623"}}